slide to see more
| Date |
Name |
Broker |
New |
Last |
Old price target |
New price target |
Broker change |
| 09-Apr-24 |
Hikma Pharmaceuticals
|
Barclays |
Equal-weight |
1,817.00p |
1,700.00p |
1,800.00p |
Reiteration |
| 26-Feb-24 |
AstraZeneca
|
Berenberg Bank |
Buy |
10,254.00p |
124.00p |
135.00p |
Reiteration |
| 16-Feb-24 |
Hikma Pharmaceuticals
|
Jefferies |
Buy |
1,987.50p |
2,080.00p |
2,125.00p |
Reiteration |
| 12-Feb-24 |
AstraZeneca
|
UBS |
Sell |
9,501.00p |
10,700.00p |
9,900.00p |
Reiteration |
| 12-Feb-24 |
AstraZeneca
|
Stifel |
Buy |
9,501.00p |
125.00p |
120.00p |
Reiteration |
| 31-Jan-24 |
Oxford Biomedica
|
RBC Capital Markets |
Outperform |
181.80p |
1,110.00p |
1,010.00p |
Reiteration |
| 26-Sep-23 |
Oxford Biomedica
|
Liberum Capital |
Hold |
291.50p |
350.00p |
310.00p |
Reiteration |
| 20-Sep-23 |
Anpario
|
Canaccord Genuity |
Buy |
245.00p |
375.00p |
340.00p |
Reiteration |